PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#pioglitazone ×

UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Approves ANDA078670 for Pioglitazone Hydrochloride Tablets
FDA has approved ANDA078670 submitted by Aiping Pharm Inc for prescription pioglitazone hydrochloride tablets in 15 mg, 30 mg, and 45 mg strengths.